SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-072365
Filing Date
2014-10-20
Accepted
2014-10-20 09:00:26
Documents
2
Period of Report
2014-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-22544_18k.htm 8-K 24207
2 EX-10.1 a14-22544_1ex10d1.htm EX-10.1 50381
  Complete submission text file 0001104659-14-072365.txt   75941
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 141163131
SIC: 2835 In Vitro & In Vivo Diagnostic Substances